Ignite Creation Date:
2024-05-06 @ 3:17 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02259114
Status:
COMPLETED
Last Update Posted:
2021-01-26
First Post:
2014-10-03
Brief Title:
A Dose-Finding Study of Birabresib MK-8628 a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal BET Proteins in Adults With Selected Advanced Solid Tumors MK-8628-003
Sponsor:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-03
First Submit QC Date:
October 3 2014
Study First Post Date:
2014-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-10-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-07
Last Update Post Date:
2021-01-26
Last Update Post Date Type:
ACTUAL